1
Winfried S Wels, Nancy E Hynes, Ina Maria Harweth, Bernd Groner, Norman Hardman, Markus Zwickl: Recombinant antibodies specific for a growth factor receptor. Ciba Geigy Corporation, James Scott Elmer, November 5, 1996: US05571894 (169 worldwide citation)

The invention concerns recombinant antibodies directed to the extracellular domain of the human growth factor receptor c-erbB-2 comprising a light chain variable domain and a heavy chain variable domain of a monoclonal antibody, monoclonal antibodies directed to c-erbB-2 themselves, a method of manu ...


2
Wels Winfried Stephan Dr, Hynes Nancy E Dr, Harwerth Ina Maria, Groner Bernd Dr, Hardman Norman Dr, Zwickl Markus: Recombinant antibodies specific for a growth factor receptor.. Ciba-Geigy, September 9, 1992: EP0502812-A1 (48 worldwide citation)

The invention concerns recombinant antibodies directed to the extracellular domain of the human growth factor receptor c-erbB-2 comprising a light chain variable domain and a heavy chain variable domain of a monoclonal antibody, monoclonal antibodies directed to c-erbB-2 themselves, a method of manu ...


3
Winfried Stephan Wels, Nancy E Hynes, Ina Maria Harwerth, Bernd Groner, Norman Hardman, Markus Zwickl: Recombinant antibodies specific for a growth factor receptor. Novartis, Hesna J Pfeiffer, August 17, 1999: US05939531 (36 worldwide citation)

The invention concerns recombinant antibodies directed to the extracellular domain of the human growth factor receptor c-erbB-2 comprising a light chain variable domain and a heavy chain variable domain of a monoclonal antibody, monoclonal antibodies directed to c-erbB-2 themselves, a method of manu ...


4
Wels Winfried S, Hynes Nancy E, Harwerth Ina Maria, Groner Bernd, Hardman Norman, Zwickl Markus: Anticorps recombinants specifiques pour un recepteur de facteur de croissance, Recombinant antibodies specific for a growth factor receptor. Ciba-Geigy, Novartis, FETHERSTONHAUGH & CO, December 3, 2002: CA2060544 (1 worldwide citation)

The invention concerns recombinant antibodies directed to the extracellular domain of thehuman growth factor receptor c-erbB-2 comprising a light chain variable domain and aheavy chain variable domain of a monoclonal antibody, monoclonal antibodies directed toc-erbB-2 themselves, a method of manufac ...



Click the thumbnails below to visualize the patent trend.